
Game-Changer for Equine OA? 2.5% Polyacrylamide Hydrogel Shows Long-Lasting Relief
In this episode Nancy McLean reviews a Tnibar (2025) literature review with seven equine studies showing 2.5% polyacrylamide hydrogel (IPAAG) provides long‑lasting, biocompatible intra‑articular relief for osteoarthritis, often reducing or resolving lameness from one month up to 24 months in many horses. The episode summarizes study outcomes, notes rapid onset in some horses (as early as one week), typical post‑injection management (about one week stall rest with hand‑walking), and highlights effects on joint capsule elasticity and viscous supplementation that may protect articular surfaces. Nancy contrasts 2.5% IPAAG with 4% products, explaining that 4% differs in manufacturing, contains silver ions, and currently has less published evidence and unclear safety compared with 2.5% IPAAG.
- Transcript
- Chapters













